Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
EP Plus Group is a leading Southeast Asian healthcare company specializing in the commercialization and distribution of innovative European pharmaceuticals and medical products. The company operates across five therapeutic areas with a focus on disease management and treatment outcomes. Its portfolio includes both prescription drugs and medical devices for chronic diseases as well as fertility sciences and medical aesthetics. Products are commercialized through exclusive partnerships with European manufacturers; clinical results are based on established efficacy of licensed brands rather than proprietary R&D.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on EP Plus Group.